FrancophonIA/ELRC3.0 huggingface dataset:
English: The recommended starting dose is Binocrit 450 IU/kg (maximum total dose is 40,000 IU) administered subcutaneously once every week, with not less than 5 days between doses.
Estonian: Binocriti soovitatav algannus on 450 RÜ/kg (maksimaalne koguannus on 40 000 RÜ), manustatuna subkutaanselt kord nädalas nõnda, et annuste vahele jääb vähemalt viis päeva.
English: Binocrit should be administered after the completion of the blood donation procedure.
Estonian: Binocriti tuleb manustada pärast vere kogumise lõpetamist.
English: Binocrit is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion.
Estonian: Binocriti kasutatakse aneemia raviks täiskasvanutel, kes saavad kemoteraapiat soliidtuumori, pahaloomulise lümfoomi või hulgimüeloomi (luuüdi vähk) tõttu ja kellel võib olla vajadus vereülekanneteks.
English: How to use Binocrit
Estonian: Kuidas Binocriti kasutada
English: Your doctor will monitor your blood pressure regularly while you are using Binocrit.
Estonian: Binocriti kasutamise ajal jälgib teie arst korrapäraselt teie vererõhku.
English: Very common side effects
Estonian: Väga sagedased kõrvaltoimed:
English: Anaemia in chronic renal failure patients before initiation of dialysis or on peritoneal dialysis
Estonian: Aneemia kroonilise neerupuudulikkusega patsientidel enne dialüüsi alustamist või kroonilise neerupuudulikkusega peritoneaaldialüüsitavatel patsientidel
English: Where intravenous access is not readily available Binocrit may be administered subcutaneously.
Estonian: Kui puudub intravenoosne manustamistee, võib Binocriti manustada subkutaanselt.
English: Binocrit is given alone and not mixed with other liquids for injection.
Estonian: Binocriti manustatakse eraldi ja seda ei segata teiste süstevedelikega.
English: Binocrit contains less than 1 mmol sodium (23 mg) per dose that is to say essentially “sodium free”.
Estonian: Binocrit sisaldab vähem kui 1 mmol (23 mg) naatriumi annuse kohta, see tähendab põhimõtteliselt „naatriumivaba”.
English: You may still be able to use Binocrit, but discuss it with your doctor first.
Estonian: Binocriti kasutamine ei pruugi olla välistatud, aga sellegipoolest pidage enne nõu oma arstiga.
English: Binocrit should be administered in order to increase haemoglobin to not greater than 11 g/dL (6.8 mmol/L).
Estonian: Binocriti manustamise eesmärgiks on saavutada hemoglobiinisisaldus, mis ei ületa 11 g/dl (6,8 mmol/l).
English: Binocrit is used to treat symptomatic anaemia caused by kidney disease:
Estonian: Binocriti kasutatakse neeruhaigusest tingitud sümptomaatilise aneemia raviks:
English: If the haemoglobin level reaches 15 g/dL (9.38 mmol/L), or higher, during the preoperative period, administration of Binocrit should be stopped and further dosages should not be administered.
Estonian: Kui hemoglobiinisisaldus jõuab preoperatiivse perioodi vereanalüüsides väärtuseni 15 g/dl (9,38 mmol/l) või ületab selle, tuleb ravi Binocritiga katkestada ja järgnevaid annuseid ei tohi manustada.
English: Only take one dose of Binocrit from each syringe.
Estonian: Võtke igast süstlist ainult üks Binocriti annus.
English: Binocrit is indicated in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre-existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.
Estonian: Binocrit on näidustatud aneemia raviks ja vereülekannete vajaduse vähendamiseks soliidtuumori, maliigse lümfoomi või hulgimüeloomiga täiskasvanutel, kes saavad keemiaravi ja kellel on oma üldseisundi tõttu risk vereülekanneteks (nt kardiovaskulaarne seisund, aneemia olemasolu enne keemiaravi alustamist).
English: Only one dose of Binocrit from each syringe should be taken.
Estonian: Igast süstlist võib võtta ainult ühe Binocriti annuse.
English: • in children on haemodialysis
Estonian: • hemodialüüsi saavatel lastel,
English: Binocrit is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):
Estonian: Binocrit on näidustatud kroonilise neerupuudulikkusega seotud sümptomaatilise aneemia raviks:
English: What is in this leaflet What Binocrit is and what it is used for What you need to know before you use Binocrit How to use Binocrit Possible side effects How to store Binocrit Contents of the pack and other information What Binocrit is and what it is used for Binocrit contains the active substance epoetin alfa, a protein that stimulates the bone marrow to produce more red blood cells which carry haemoglobin (a substance that transports oxygen).
Estonian: Mis ravim on Binocrit ja milleks seda kasutatakse Mida on vaja teada enne Binocriti kasutamist Kuidas Binocriti kasutada Võimalikud kõrvaltoimed Kuidas Binocriti säilitada Pakendi sisu ja muu teave
English: The recommended total weekly dose is between 75 IU/kg and 300 IU/kg.
Estonian: Soovitatav annus on 75 kuni 300 RÜ/kg nädalas.
English: Binocrit is used to treat anaemia in adults with a bone marrow disorder that causes a severe disruption in the creation of blood cells (myelodysplastic syndromes).
Estonian: Binocriti kasutatakse aneemia raviks vererakkude moodustamist tugevalt kahjustava luuhäirega (müelodüsplastiline sündroom) täiskasvanutel.
English: Binocrit is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.
Estonian: Binocrit on näidustatud allogeense vereülekande vajaduse vähendamiseks enne ulatuslikku ortopeedilist lõikust täiskasvanutel, kellel ei esine rauavaegustja on suurenenud risk vereülekannetega seotud tüsistuste tekkeks.
English: Side effects from an overdose of Binocrit are unlikely.
Estonian: Binocriti üleannustamise järgselt on kõrvaltoimete esinemine ebatõenäoline.
English: Binocrit may be given by injection:
Estonian: Binocriti võib manustada süstides:
English: Epoetin alfa exhibits a dose-related effect on haematological parameters which is independent of route of administration.
Estonian: Alfaepoetiinil on hematoloogilistele näitajatele annusest sõltuv toime, mis ei sõltu manustamisteest.
English: You may still be able to use Binocrit, but discuss it with your doctor first:
Estonian: Binocriti kasutamine ei pruugi olla välistatud, aga sellegipoolest pidage enne nõu oma arstiga, kui
English: In patients with chronic renal failure where intravenous access is routinely available (haemodialysis patients) administration of Binocrit by the intravenous route is preferable.
Estonian: Kroonilise neerupuudulikkusega patsientidel, kellel on olemas intravenoosne juurdepääs (hemodialüüsitavad patsiendid), on eelistatud Binocriti intravenoosne manustamine.
English: Binocrit should be administered as a subcutaneous injection.
Estonian: Binocriti tuleb manustada subkutaanselt.
English: - All contraindications associated with autologous blood predonation programmes should be respected in patients being supplemented with Binocrit.
Estonian: - Binocriti kasutavate patsientide puhul tuleb arvestada kõigi autoloogse vere eelneva kogumise programmiga seonduvate vastunäidustustega.
English: Binocrit should be administered by the intravenous route.
Estonian: Binocriti tuleb manustada intravenoosselt.
English: How to store Binocrit
Estonian: Kuidas Binocriti säilitada
English: If the haemoglobin concentration is increasing by more than 2 g/dL (1.25 mmol/L) per month, or if the haemoglobin concentration level exceeds 12 g/dL (7.5 mmol/L), reduce the Binocrit dose by about 25 to 50%.
Estonian: Kui hemoglobiinisisaldus tõuseb ühe kuu kohta rohkem kui 2 g/dl (1,25 mmol/l) või kui hemoglobiinisisaldus ületab 12 g/dl (7,5 mmol/l), vähendage Binocriti annust ligikaudu 25 kuni 50%.
English: Use should be restricted to patients with moderate anaemia (e.g. haemoglobin concentration range between 10 to 13 g/dL or 6.2 to 8.1 mmol/L) who do not have an autologous predonation programme available and with expected moderate blood loss (900 to 1,800 mL).
Estonian: 10 kuni 13 g/dl või 6,2 kuni 8,1 mmol/l), kui autoloogse vere kogumine pole võimalik ja eeldatav verekaotus on mõõdukas (900 kuni 1800 ml).
English: Patients should be monitored closely to ensure that the lowest approved dose of Binocrit is used to provide adequate control of anaemia and of the symptoms of anaemia.
Estonian: Patsiente tuleb hoolikalt jälgida veendumaks, et neil esineva aneemia ja aneemia sümptomite adekvaatseks raviks kasutatakse madalaimat vajalikku Binocriti annust.
English: Once a syringe has been removed from the refrigerator and has reached room temperature (up to 25°C) it must either be used within 3 days or disposed of.
Estonian: Kui süstel on külmkapist välja võetud ja soojenenud toatemperatuurini (kuni 25°C),
English: If the haemoglobin exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinstitute Binocrit therapy at a dose 25% below the previous dose.
Estonian: Kui hemoglobiinisisaldus ületab 13 g/dl (8,1 mmol/l), katkestage ravi, kuni hemoglobiinisisaldus langeb alla 12 g/dl (7,5 mmol/l) ja seejärel taasalustage ravi Binocritiga varasemast 25% väiksema annusega.
English: Treatment of adult surgery patients in an autologous predonation programme
Estonian: Täiskasvanud operatsioonieelsete patsientide ravi autoloogse vere eelneva kogumise programmi käigus
English: Take special care with Binocrit:
Estonian: Eriline ettevaatus on vajalik ravimiga Binocrit
English: If the haemoglobin is rising by more than 2 g/dL (1.25 mmol/L) per month, or if the sustained haemoglobin exceeds 12 g/dL (7.5 mmol/L) reduce the Binocrit dose by 25%.
Estonian: Kui hemoglobiinisisaldus suureneb ühe kuu kohta rohkem kui 2 g/dl (1,25 mmol/l) või kui püsiv hemoglobiinisisaldus on üle 12 g/dl (7,5 mmol/l), vähendage Binocriti annust 25% võrra.
English: Binocrit should be administered in order to increase haemoglobin to not greater than 12 g/dL (7.5 mmol/L).
Estonian: Binocriti manustamise eesmärgiks on saavutada hemoglobiinisisaldus, mis ei ületa 12 g/dl (7,5 mmol/l).
English: Binocrit should be administered to patients with symptomatic anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)).
Estonian: Binocriti tuleb manustada sümptomaatilise aneemiaga (nt hematoglobiinisisaldus ≤ 10 g/dl (6,2 mmol/l))
English: Do not shake Binocrit syringes.
Estonian: Binocriti süstleid ei tohi loksutada.
English: The starting dose is 50 IU/kg, 2 times per week.
Estonian: Algannus on 50 RÜ/kg 2 korda nädalas.
English: Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Each syringe contains 0.9 mL of solution for injection.
Estonian: Binocrit 9000 RÜ/0,9 ml süstelahus süstlis Üks süstel sisaldab 0,9 ml lahust.
English: Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Each syringe contains 0.8 mL of solution for injection.
Estonian: Binocrit 8000 RÜ/0,8 ml süstelahus süstlis Üks süstel sisaldab 0,8 ml lahust.
English: INFORMATION IN BRAILLE Binocrit 8,000 IU/0.8 mL
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Binocrit 8000 RÜ/0,8 ml
English: Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Each syringe contains 0.75 mL of solution for injection.
Estonian: Binocrit 30 000 RÜ/0,75 ml süstelahus süstlis Üks süstel sisaldab 0,75 ml lahust.
English: Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Each syringe contains 0.7 mL of solution for injection.
Estonian: Binocrit 7000 RÜ/0,7 ml süstelahus süstlis Üks süstel sisaldab 0,7 ml lahust.
English: INFORMATION IN BRAILLE Binocrit 30,000 IU/0.75 mL
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Binocrit 30 000 RÜ/0,75 ml
English: Patients were stratified according to their baseline haemoglobin (≤ 10 g/dL, > 10 to ≤ 13 g/dL and > 13 g/dL).
Estonian: > 10 kuni ≤ 13 g/dl ja > 13 g/dl).
English: INFORMATION IN BRAILLE Binocrit 7,000 IU/0.7 mL
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Binocrit 7000 RÜ/0,7 ml
English: (subcutaneously) yourself.
Estonian: • te imetate.
English: Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Each syringe contains 0.6 mL of solution for injection.
Estonian: Binocrit 6000 RÜ/0,6 ml süstelahus süstlis Üks süstel sisaldab 0,6 ml lahust.
English: INFORMATION IN BRAILLE Binocrit 9,000 IU/0.9 mL
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Binocrit 9000 RÜ/0,9 ml
English: • Binocrit is given by injection under the skin.
Estonian: • Binocriti manustatakse nahaaluse süstena.
English: Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe EU/1/07/410/013
Estonian: Binocrit 8000 RÜ/0,8 ml süstelahus süstlis EU/1/07/410/013
English: Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Each syringe contains 0.4 mL of solution for injection.
Estonian: Binocrit 4000 RÜ/0,4 ml süstelahus süstlis Üks süstel sisaldab 0,4 ml lahust.
English: INFORMATION IN BRAILLE Binocrit 6,000 IU/0.6 mL
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Binocrit 6000 RÜ/0,6 ml
English: INFORMATION IN BRAILLE Binocrit 40,000 IU/1 mL
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Binocrit 40 000 RÜ/1 ml
English: Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe EU/1/07/410/011
Estonian: Binocrit 6000 RÜ/0,6 ml süstelahus süstlis EU/1/07/410/011
English: Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe EU/1/07/410/023
Estonian: Binocrit 30 000 RÜ/0,75 ml süstelahus süstlis EU/1/07/410/023
English: What Binocrit looks like and contents of the pack Binocrit is presented as a clear, colourless solution for injection in a pre-filled syringe.
Estonian: Binocrit on selge, värvitu süstelahus süstlis.
English: Binocrit is one of a group of products that stimulate the production of red blood cells like the human protein erythropoietin does.
Estonian: Olge teiste vere punaliblede produktsiooni stimuleerivate toodetega eriti ettevaatlik Binocrit kuulub ravimiterühma, mis stimuleerivad vere punaliblede produktsiooni sarnaselt inimvalgu erütropoetiinile.
English: INFORMATION IN BRAILLE Binocrit 4,000 IU/0.4 mL
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Binocrit 4000 RÜ/0,4 ml
English: INFORMATION IN BRAILLE Binocrit 5,000 IU/0.5 mL
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Binocrit 5000 RÜ/0,5 ml
English: Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/410/009
Estonian: Binocrit 5000 RÜ/0,5 ml süstelahus süstlis EU/1/07/410/009
English: INFORMATION IN BRAILLE Binocrit 3,000 IU/0.3 mL
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Binocrit 3000 RÜ/0,3 ml
English: Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe EU/1/07/410/019
Estonian: Binocrit 9000 RÜ/0,9 ml süstelahus süstlis EU/1/07/410/019
English: Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe
Estonian: Binocrit 6000 RÜ/0,6 ml süstelahus süstlis
English: Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe
Estonian: Binocrit 9000 RÜ/0,9 ml süstelahus süstlis
English: Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe
Estonian: Binocrit 8000 RÜ/0,8 ml süstelahus süstlis Alfaepoetiin
English: INFORMATION IN BRAILLE Binocrit 20,000 IU/0.5 mL
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Binocrit 20 000 RÜ/0,5 ml
English: INFORMATION IN BRAILLE Binocrit 1,000 IU/0.5 mL
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Binocrit 1000 RÜ/0,5 ml
English: Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe EU/1/07/410/017
Estonian: Binocrit 7000 RÜ/0,7 ml süstelahus süstlis EU/1/07/410/017
English: Binocrit 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Each syringe contains 0.3 mL of solution for injection.
Estonian: Binocrit 3000 RÜ/0,3 ml süstelahus süstlis Üks süstel sisaldab 0,3 ml lahust.
English: What Binocrit contains - The active substance is: epoetin alfa (for quantity see the table below).
Estonian: - Toimeaine on alfaepoetiin (kogused vt allolevast tabelist).
English: Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe
Estonian: Binocrit 7000 RÜ/0,7 ml süstelahus süstlis
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 30,000 IU/0.75 mL injection
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE(D) Binocrit 30 000 RÜ/0,75 ml süstevedelik Alfaepoetiin i.v./s.c.
English: INFORMATION IN BRAILLE Binocrit 10,000 IU/1 mL
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Binocrit 10 000 RÜ/1 ml
English: Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe EU/1/07/410/007
Estonian: Binocrit 4000 RÜ/0,4 ml süstelahus süstlis EU/1/07/410/007
English: Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Estonian: Binocrit 40 000 RÜ/1 ml süstelahus süstlis Üks süstel sisaldab 1 ml lahust.
English: Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/410/025
Estonian: Binocrit 40 000 RÜ/1 ml süstelahus süstlis EU/1/07/410/025
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 9,000 IU/0.9 mL injection
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE(D) Binocrit 9000 RÜ/0,9 ml süstevedelik Alfaepoetiin i.v./s.c.
English: Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/410/021
Estonian: Binocrit 20 000 RÜ/0,5 ml süstelahus süstlis EU/1/07/410/021
English: Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe
Estonian: Binocrit 4000 RÜ/0,4 ml süstelahus süstlis
English: Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Estonian: Binocrit 1000 RÜ/0,5 ml süstelahus süstlis Üks süstel sisaldab 0,5 ml lahust.
English: Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Estonian: Binocrit 5000 RÜ/0,5 ml süstelahus süstlis Üks süstel sisaldab 0,5 ml lahust.
English: Binocrit 3,000 IU/0.3 mL solution for injection in a pre-filled syringe EU/1/07/410/005
Estonian: Binocrit 3000 RÜ/0,3 ml süstelahus süstlis EU/1/07/410/005
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 8,000 IU/0.8 mL injection
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE(D) Binocrit 8000 RÜ/0,8 ml süstevedelik Alfaepoetiin i.v./s.c.
English: Binocrit should be administered to patients with anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)).
Estonian: Aneemiaga patsientidele (nt hemoglobiini kontsentratsioon ≤ 10 g/dl ehk 6,2 mmol/l) tuleb manustada
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 6,000 IU/0.6 mL injection
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE(D) Binocrit 6000 RÜ/0,6 ml süstevedelik Alfaepoetiin i.v./s.c.
English: Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Estonian: Binocrit 20 000 RÜ/0,5 ml süstelahus süstlis Üks süstel sisaldab 0,5 ml lahust.
English: Binocrit 10,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/410/015
Estonian: Binocrit 10 000 RÜ/1 ml süstelahus süstlis EU/1/07/410/015
English: Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Epoetin alfa
Estonian: Binocrit 30 000 RÜ/0,75 ml süstelahus süstlis
English: Binocrit 10,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Estonian: Binocrit 10 000 RÜ/1 ml süstelahus süstlis Üks süstel sisaldab 1 ml lahust.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 4,000 IU/0.4 mL injection
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE(D) Binocrit 4000 RÜ/0,4 ml süstevedelik Alfaepoetiin i.v./s.c.
English: Treatment of symptomatic anaemia in paediatric chronic renal failure patients on haemodialysis
Estonian: Lapsed Sümptomaatilise aneemia ravi kroonilise neerupuudulikkusega patsientidel, kes saavad hemodialüüsi
English: Binocrit 3,000 IU/0.3 mL solution for injection in a pre-filled syringe
Estonian: Binocrit 3000 RÜ/0,3 ml süstelahus süstlis
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 5,000 IU/0.5 mL injection
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE(D) Binocrit 5000 RÜ/0,5 ml süstevedelik Alfaepoetiin i.v./s.c.
English: Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe
Estonian: Binocrit 40 000 RÜ/1 ml süstelahus süstlis Alfaepoetiin
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 3,000 IU/0.3 mL injection
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE(D) Binocrit 3000 RÜ/0,3 ml süstevedelik Alfaepoetiin i.v./s.c.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 1,000 IU/0.5 mL injection
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE(D) Binocrit 1000 RÜ/0,5 ml süstevedelik Alfaepoetiin i.v./s.c.
English: Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per mL
Estonian: Iga ml lahust sisaldab 2000 RÜ alfaepoetiini*, mis vastab 16,8 mikrogrammile/ml.
English: INFORMATION IN BRAILLE Binocrit 2,000 IU/1 mL
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Binocrit 2000 RÜ/1 ml
English: Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/410/003
Estonian: Binocrit 2000 RÜ/1 ml süstelahus süstlis EU/1/07/410/003
English: Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/410/001
Estonian: Binocrit 1000 RÜ/0,5 ml süstelahus süstlis EU/1/07/410/001
English: Binocrit 10,000 IU/1 mL solution for injection in a pre-filled syringe
Estonian: Binocrit 10 000 RÜ/1 ml süstelahus süstlis
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 40,000 IU/1 mL injection
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE(D) Binocrit 40 000 RÜ/1 ml süstevedelik Alfaepoetiin i.v./s.c.
English: Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe
Estonian: Binocrit 5000 RÜ/0,5 ml süstelahus süstlis
English: Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe
Estonian: Binocrit 20 000 RÜ/0,5 ml süstelahus süstlis
English: Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe
Estonian: Binocrit 1000 RÜ/0,5 ml süstelahus süstlis Alfaepoetiin
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 20,000 IU/0.5 mL injection
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE(D) Binocrit 20 000 RÜ/0,5 ml süstevedelik Alfaepoetiin i.v./s.c.
English: Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Estonian: Iga ml lahust sisaldab 40 000 RÜ alfaepoetiini*, mis vastab 336,0 mikrogrammile/ml.
English: Binocrit 10,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Estonian: Iga ml lahust sisaldab 10 000 RÜ alfaepoetiini*, mis vastab 84,0 mikrogrammile/ml.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 10,000 IU/1 mL injection
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE(D) Binocrit 10 000 RÜ/1 ml süstevedelik Alfaepoetiin i.v./s.c.
English: Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Estonian: Binocrit 2000 RÜ/1 ml süstelahus süstlis Üks süstel sisaldab 1 ml lahust.
English: Epoetin alfa
Estonian: Annuse suurendamine.
English: Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe
Estonian: Binocrit 2000 RÜ/1 ml süstelahus süstlis
English: Binocrit contains sodium
Estonian: Binocrit sisaldab naatriumi:
English: EMA/HMPC/322933/2013
Estonian: EMA/HMPC/322933/2013 Taimsete ravimite komitee (HMPC)
English: It can be used in adults or children over the age of 6 years.
Estonian: Seda võivad kasutada täiskasvanud ja üle 6-aastased lapsed.